Related by context. All words. (Click for frequent words.) 80 Files Investigational 76 Files IND 76 Receives Approvable Letter 75 Submits NDA 75 Initiates Clinical Trial 74 Initiates Phase II 74 Resubmission 74 Submits Response 74 Initiates Phase III 74 Submits Supplemental 73 Submits IND 73 Submits Biologics License Application 73 Completes Patient Enrollment 73 Announces Tentative Approval 73 FDA Accepts 73 Initiates Enrollment 73 Initiates Clinical 72 Receives Orphan Drug Designation 72 Oral Calcitonin 72 Initiates Phase 2b 72 Drug Fails 72 IND Application 72 FDA Approvable Letter 72 Receives Milestone Payment 72 Presents Positive 72 Successfully Completes Phase 71 Granted Orphan Drug 71 Receives Orphan Drug 71 Receives Complete Response 71 Initiate Clinical Trial 71 Begins Dosing 71 Resubmits 71 Completes Enrollment 70 Presents Preclinical Data 70 Biologic License Application 70 BioSante Pharmaceuticals Announces 70 Presents Preclinical 70 Receives Tentative Approval 70 Supplemental Biologics License Application 69 Submits Application 69 NDA Submission 69 Reports Preclinical Data 69 Licenses Novel 69 Voluntarily Withdraws 69 Investigational Compound 69 Commences Phase 69 Receives Favorable 69 FDA Approvals 69 Initiate Phase 68 Presents Positive Preclinical 68 Phase 2b Clinical Trial 68 Phase IIa Clinical Trial 68 Investigational Treatment 68 Therapeutic Competitors Companies 68 Launches Generic Version 68 Meets Primary Endpoint 68 Phase 2a Trial 68 Psoriasis Drug 68 Pivotal Phase III 68 Xcytrin R 68 FDA Okays 68 Vitrasert R 68 Drug Candidate 67 Begin Clinical Trials 67 Teva Provides Update 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 Receives Fast Track 67 Present Preclinical Data 67 Fast Track Status 67 Announce Licensing Agreement 67 Protease Inhibitor 67 markets HP Acthar 67 Announces Poster Presentations 67 non nucleoside inhibitor 67 Pivotal Study 67 Transcept Pharmaceuticals 67 Lung Cancer Drug 67 Gets FDA Clearance 67 Demonstrates Significant 67 Receive Milestone Payment 67 Demonstrates Positive 67 Phase III Clinical Trial 67 Patient Enrollment 67 FDA Clears 67 Arthritis Drug 66 FOLOTYN ® 66 Lupus Drug 66 SYCREST 66 Prostate Cancer Vaccine 66 KRYSTEXXA TM pegloticase 66 Phase IIb Clinical Trial 66 Earns Milestone Payment 66 Cites Positive 66 Achieves Primary Endpoint 66 Demonstrates Efficacy 66 Enrolls First 66 Awarded Qualifying Therapeutic 66 Initiates Phase 66 Novel Antibiotic 66 Announces FDA Clearance 66 Levoleucovorin 66 pralatrexate injection folate analogue 66 JAK2 Inhibitor 66 VIVUS Announces 66 Issues Complete Response 66 Receives Positive Opinion 66 Announce License Agreement 66 Collaborators Present 66 Clinical Trial Results 66 Receives Approval From 66 Kuvan TM sapropterin 66 Initiates Dosing 66 phase III isavuconazole 66 Announce Collaboration Agreement 66 Pafuramidine 66 LibiGel ® 66 Completes Dosing 66 Taro Receives 66 IND Filing 66 Personalized Immunotherapy 66 Initiates Clinical Trials 66 Initiate Phase III 66 BRILINTA 66 Advanced Melanoma 66 Pivotal Trial 66 Premarket Approval Application 65 Valortim TM 65 IG HCR ;) CO 65 Dose Ranging Study 65 PDUFA Date 65 lucinactant 65 VIVITROL ® 65 Receives FDA Clearance 65 Aztreonam Lysine 65 Receives Tentative FDA 65 Transdermal Patch 65 Systemic Delivery 65 Commence Phase 65 Investigational Oral 65 Saforis 65 Expanded Indication 65 balsalazide tablet 65 Marketing Authorisation Application MAA 65 Epilepsy Drug 65 Phase 2b Trial 65 proprietary intravenous formulation 65 Risperidone Oral Solution 65 Prolongs Survival 65 R MSCRAMM 65 Amends Stockholder Rights 65 Generic Version 65 Phase IIb Trial 65 Receives Conditional 65 PRN FDA Approves 65 Inhaled Insulin 65 Extended Release Capsules 65 Nasdaq ACHN 65 Gout Drug 65 Migraine Drug 65 Orphan Status 65 Release Capsules 65 gets USFDA nod 65 MKC# MT 65 Patients Treated With 65 Recommends Approval 65 Study Evaluating 65 Mylan Receives Approval 65 Febuxostat 65 Romiplostim 65 ATPace TM 65 LymphoStat B TM 65 Bazedoxifene 65 Hydrochlorothiazide Tablets 65 HDAC Inhibitor 65 Effectively Treats 65 Bosutinib 65 successfully commercialize Iluvien 65 Drug Shows Promise 65 Tramiprosate ALZHEMED TM 65 Voluntarily Withdraw 64 hoFH 64 Ropinirole 64 Pegloticase 64 Develop Novel 64 novel emulsion formulation 64 BEMA Granisetron 64 submitted Biologics License 64 FDA Approves Generic 64 Demonstrates Potential 64 Adjunctive Therapy 64 OTC Zegerid 64 Sign Licensing Agreement 64 Preclinical Data 64 Investigational Drug 64 Receives NASDAQ 64 Surfaxin lucinactant 64 Generic Versions 64 Crofelemer budesonide foam 64 Clinical Trial Evaluating 64 Announces Initiation 64 Panzem R 64 Pivotal Phase 64 Severe Sepsis 64 TELINTRA R 64 Announce Merger Agreement 64 OLEPTRO 64 Phase III Pivotal 64 Liprotamase 64 Confirms Efficacy 64 Elagolix 64 Demonstrates Statistically Significant 64 Receives CE Marking 64 Romidepsin 64 developing Zerenex ferric 64 oral beclomethasone dipropionate 64 SinuNase ™ 64 Single Dose 64 Nasdaq VNDA 64 Shows Promise Against 64 Demonstrates Sustained 64 Muraglitazar 64 BioDelivery Sciences Announces 64 Generic Version Of 64 Novel Oral 64 Phase 1b Clinical Trial 64 Anturol TM 64 Vertex hepatitis C 64 Aloxi ® 64 Schizophrenia Drug 64 Hematological Malignancies 64 Receives Positive 64 Barr ANDA 64 Approvable 64 CIP TRAMADOL ER 64 sNDAs 64 Pivotal Clinical Trial 64 Anticancer Drug 64 Begins Clinical Trial 64 Receives Unsolicited 64 Inc. Nasdaq OXGN 64 Augment ™ 64 Tezampanel 64 include Phenoptin TM 64 ANDA Filing 64 Multiple Ascending Dose 64 Vicriviroc 64 candidate REP# 64 SPL# Gel vaginal microbicide 64 Sumatriptan Succinate 64 Intravenous Formulation 63 Amends Agreement 63 Files Provisional 63 Trial Evaluating 63 R sipuleucel T 63 mesylate tablets approved 63 Phase III Trial 63 vapreotide acetate 63 intranasal formulation 63 FDA Approves 63 Nasdaq SLXP 63 markets COLAZAL 63 oral prodrug 63 Announces Favorable 63 Reacquires 63 Carbidopa Levodopa 63 HCV RNA polymerase 63 Announces Licensing Agreement 63 Inc Therapeutic Competitors 63 Files Shelf Registration Statement 63 SPRYCEL ® 63 ® decitabine 63 hyaluronidase enzyme 63 Panzem ® 63 Generic Lovenox 63 Vitrasert ® 63 Reveals Positive 63 Receives Clearance 63 BiovaxID TM 63 Entry Inhibitor 63 Phase III Trials 63 rasagiline tablets 63 Milestone Payment 63 personalized dendritic 63 Biological License Application 63 First Patient Enrolled 63 Grants Orphan Drug 63 Restructures Operations 63 Pandemic Flu Vaccine 63 PROVENGE ® 63 Velaglucerase Alfa 63 Theratechnologies submitted 63 Ondansetron Injection 63 Velac 63 FDA Panel Recommends 63 Friedreich Ataxia FRDA 63 Improves Outcomes 63 acyclovir Lauriad R 63 Prodarsan R 63 Cintredekin besudotox 63 Blood Pressure Drug 63 Glatiramer Acetate 63 AAG geldanamycin analog 63 Nasdaq EPCT 63 Regains Full 63 topical gel formulation 63 Therapeutic Competitors Report 63 Extended Release 63 IL# PE#QQR 63 Confirmatory Phase 63 Extended Release Tablets 63 Prodrug 63 Efficacy Results 63 Dyloject TM 63 Rotavirus Vaccine 63 Genentech sanofi aventis 63 methylnaltrexone bromide 63 MAGE A3 ASCI 63 Iluvien ® 63 Therapeutic Vaccine 63 Pruvel 63 Provides Update Regarding 63 RDYN 63 Phase III multicenter 63 2 methoxyestradiol 63 Cholesterol Drug 63 PrevOnco 63 JAK Inhibitor 63 OTCBB GNTA 63 PF # [002] 63 Indomethacin 63 Thelin TM 63 Biologic License Application BLA 63 Efficacy Trial 63 inhalation powder 63 Recombinant Human 63 NASDAQ INSM 63 Valtropin 63 Nipent R 63 Oxytrex TM 63 Parathyroid Hormone 63 EVIZON TM 63 combines bupropion 63 Therapeutic Antibody 63 SinuNase TM 63 Morphine Sulfate 63 Combination REOLYSIN R 63 Kinase Inhibitor 63 Receives Favorable Ruling 63 sitaxsentan sodium 63 Obtains FDA 63 proprietary intranasal insulin 63 Tesamorelin 63 Nasdaq DVAX 63 Patient Enrolment 63 miconazole Lauriad R 63 VitiGam TM 63 subsidiaries visit http:/www.apricusbio.com 63 Phase 2b Study 63 FDA APPROVES 63 Phase 2a Clinical Trial 63 Receives Subpoena 63 Cypress Bioscience Inc 63 MBRX 62 Toremifene 62 Genotyping Test 62 Prochymal TM 62 Nasdaq IDIX 62 acetonide FA 62 faropenem medoxomil 62 XL# anticancer compounds 62 MOVIPREP R 62 apricitabine ATC 62 Receives Patent 62 Orapred ODT 62 5 HT3 antagonist 62 Osteoporosis Drug 62 Hedgehog Pathway Inhibitor 62 Luveniq 62 including eniluracil ADH 62 Cholesterol Lowering Drug 62 NASDAQ VPHM 62 Testosterone MDTS ® 62 Identifies Potential 62 ARRY # 62 GTC recombinant form 62 Expedited Review 62 Injection Site 62 Biomarker Study 62 Horizant ™ 62 Anturol ® 62 Nasdaq SPPI 62 Combination Treatment 62 Replacement Therapy 62 Phase III Clinical Trials 62 candidate deforolimus 62 Genasense ® oblimersen 62 HP Acthar Gel repository 62 corticotropin injection 62 Small Molecule 62 sterile lidocaine patch 62 Application MAA 62 NASDAQ BDSI 62 Medisorb ® 62 OMAPRO ™ 62 Marketing Authorisation Application 62 balsalazide disodium Capsules 62 Inhaled Liposomal Ciprofloxacin 62 RELOVAIR ™ 62 Announce Initiation 62 Reports Positive 62 DP VPA 62 Schizophrenia Treatment 62 treat chronic sinusitis 62 Maribavir 62 GLP1 INT TM 62 Shows Statistically Significant 62 Sign License Agreement 62 Updates Status 62 Adventrx Pharmaceuticals 62 Nasdaq CTIC 62 Bacterin develops manufactures 62 HCl Injection 62 Receives FDA Approvable 62 Announce Receipt 62 Collaborators Publish 62 Inc SPPI 62 Files Voluntary 62 Lenocta TM 62 COLAZAL ® 62 Civacir 62 GATTEX TM 62 Disease Modifying 62 POSIDUR TM 62 Shows Promising 62 POSIDUR TM ELADUR TM 62 Shows Promise 62 TNF Blockers 62 Gets Tentative 62 Intravitreal 62 submitted supplemental Biologics 62 treat secondary hyperparathyroidism 62 LibiGel transdermal testosterone gel 62 Adjuvant Treatment 62 nasal calcitonin product 62 Receives Conditional Approval 62 Tyrosine Kinase Inhibitor 62 Shows Efficacy 62 Topical Treatment 62 MKC# MKC# PP 62 Announces Positive 62 KRYSTEXXA TM 62 Metabolic Disorder 62 CRTX 62 Anti infective 62 Metformin HCl 62 Nasdaq PGNX 62 selective estrogen receptor modulator 62 Oral Insulin 62 Receives Marketing Authorization 62 Oral Formulation 62 Restanza TM 62 FDA Complete Response 62 developing ACAPODENE 62 Announces Stockholder Approval 62 Eszopiclone 62 Kuvan R 62 Spectrum Pharmaceuticals Announces 62 Pivotal Trials 62 Slows Progression 62 Release Tablets 62 RNAi Therapeutic 62 Inc. OTCBB ALRX 62 Receives Notice 62 Commences Phase III 62 Tramadol ER 62 NeuroSTAT ® 62 Nabi HB Intravenous 62 please visit http:/www.vandapharma.com 62 Milestone Payments 62 NASDAQ ADLR 62 Kamada AAT 62 generation purine nucleoside 62 Inc. Nasdaq ANSV 62 Jumps Higher 62 Obtains Exclusive License 62 Telavancin 62 Zenvia ™ 62 Vaccine Adjuvant 61 Tentative Approval 61 Patent Upheld 61 tiapamil 61 Iloperidone 61 histamine dihydrochloride 61 Oxybutynin 61 Oral Suspension USP 61 PROGENSA R 61 Issues Guidance 61 proprietary radiolabeled monoclonal 61 Integrase Inhibitor 61 dextromethorphan quinidine 61 oncolytic virus therapies 61 Sanctura XR 61 Inc. Nasdaq INSM 61 Clinical Trial Data 61 Initiate Phase II 61 Nasdaq PARD 61 Phase IIA 61 highly purified pasteurized 61 GVAX ® 61 oral salmon calcitonin 61 CONBRIZA 61 Prospective Randomized 61 please visit www.eisai.com 61 Nasdaq HALO 61 arsenic trioxide injection 61 Corp. NASDAQ CYTR 61 liver resection surgeries 61 granted Ortec 61 Clinical Study Shows 61 Hsp# Inhibitor 61 Amex PTN 61 Fibrocell Science Inc. 61 RANK Ligand inhibitor 61 hypoxia activated prodrug 61 Mycophenolate Mofetil 61 IND Investigational New 61 Complete Response 61 Opterone R 61 Tablet Formulation 61 Myoblast 61 Surfactant Technology 61 Multaq dronedarone 61 Weight Loss Drug 61 Evoltra ® 61 Desvenlafaxine Succinate 61 Matrix Phase 2b 61 Inc. OTCBB SPRX 61 novel histone deacetylase 61 Fentanyl Patch 61 Patent Covering 61 Pandemic Influenza Vaccine 61 Immunomedics Announces 61 Inc. NASDAQ QLTI 61 TM Aganocide 61 Withdraws Application 61 investigational humanized monoclonal antibody 61 Receives Regulatory 61 induced macular edema 61 Settle Patent Litigation 61 Vion Pharmaceuticals 61 Peginterferon alfa 2b 61 Avian Influenza Vaccine 61 PDX pralatrexate 61 R lenalidomide 61 Submits Revised 61 SILENOR 61 Trobalt 61 Antibody Drug Conjugate 61 Nasdaq IMMU 61 TRANSDUR ® 61 sumatriptan succinate injection 61 Albugon 61 MetroGel 61 LEVADEX TM 61 SABER ™ 61 Pharmacokinetic Study 61 visit www.noven.com 61 Ltd Therapeutic Competitors 61 cromolyn sodium 61 Terminates Agreement 61 Reports Receipt 61 ALN HPN 61 RNAi Therapeutics 61 Drug Submission 61 Nicotine Vaccine 61 Nasdaq ANPI 61 rhIGF-I/rhIGFBP-3 61 Nasdaq AVNC 61 MAb therapy 61 vaginally administered lidocaine 61 TRACON Pharmaceuticals 61 TSPT 61 please visit http:/www.atherogenics.com 61 LymphoStat B belimumab 61 Obtains CE Mark 61 HEPLISAV TM 61 Premarket Approval PMA 61 topically administered 61 Isis Pharma 61 FOR FURTHER INFORMATION ABOUT 61 Qutenza TM 61 selective A2A adenosine receptor 61 Transdel Pharmaceuticals Inc. 61 PROLOR Biotech Inc. 61 SBIR Grant 61 Amlodipine Besylate 61 Demonstrates Potent 61 anti botulism antibody 61 Receives Notification 61 antidepressant trazodone 61 Milestone Payment From 61 NASDAQ PPDI 61 humanized therapeutic 61 Significantly Reduces 61 Rheumatoid Arthritis Drug 61 Issued Patent 61 Calcium Acetate 61 Immunotherapeutic 61 Aeolus Pharmaceuticals Announces 61 Inc. NASDAQ AGIX 61 Deferiprone 61 Testosterone Gel 61 Tykerb lapatinib 61 platform HDL Mimetic 61 essential thrombocythemia ET 61 Board Unanimously Rejects 61 albiglutide 61 Low Dose 61 Tech DVAX 61 Archexin 61 #mg/#mg 61 Arthritis Drugs 61 Ercole Biotech 61 NasdaqGM NTEC today 61 novel MetAP 2 61 BioGlue R 61 Aryplase 61 Nasdaq CYTX 61 Sinks Lower 61 DuraSite R 61 markets XIFAXAN ® 61 Inc. Nasdaq MITI 61 Early Relapsing Multiple 61 Bayer Onyx 61 Exherin 61 octreotide acetate 61 Pazopanib 61 hydrochloride capsules 61 Genentech Provides Update 61 Optimer Pharma 61 Reduces Mortality 61 Taclonex Scalp R 61 Oral Spray 61 supplemental biologics 61 Tibotec BVBA 61 pioglitazone hydrochloride 61 Conditional Approval 61 visit http:/www.mannkindcorp.com 61 FACTIVE R gemifloxacin 61 HCl capsules 61 Seeks Approval 61 AVI BioPharma Announces 61 Anti Tumor 61 Long Term Efficacy 61 Seasonal Influenza Vaccine 61 NUEDEXTA ™ 61 Preclinical Models 61 Granulocyte Colony Stimulating Factor 61 Cethrin R 61 initiated Phase Ib 61 Resubmit 61 Regains NASDAQ 61 Safinamide 61 Medoxomil 61 Partnering Agreements 61 Preliminary Injunction Against 61 NYSE Amex PBTH 61 Inc. OTCBB VYTR 61 PI3K/Akt pathway inhibitor 61 Advancis Pharmaceutical Corporation 61 Nasdaq MNKD focused 61 Announces Presentation 61 Cell Transplants 61 Obtains License 61 Silodosin 61 COLAZAL R 61 please visit www.middlebrookpharma.com 61 Nasdaq SGEN 61 Q3 Loss Widens 61 delivers fluocinolone acetonide FA 60 Announces Dismissal 60 Develops Novel 60 Acute Attacks 60 molecular imaging radiopharmaceutical 60 Phase Ib Clinical Trial 60 BENLYSTA ® 60 Orally Disintegrating Tablets 60 NASDAQ RNAI 60 Indevus Pharma 60 Completes Merger With 60 AUDIO PROVIDED BY 60 investigational antibiotic 60 Files Patent Application 60 Wins Patent Infringement 60 banned Darvon Darvocet 60 Nasdaq ENMD 60 HepeX B TM 60 VYVANSE TM lisdexamfetamine 60 Announces Dosing 60 Receives SFDA Approval 60 AVAPRO 60 Fibrin Sealant 60 P#X# antagonist 60 Synerx Pharma 60 application sNDA 60 vinorelbine tartrate 60 NASDAQ VVUS 60 Receives Notice Related 60 Patients Receiving 60 Potent Antiviral Activity 60 Appears Safe 60 Nasdaq IMGN 60 Nasdaq SNSS 60 Treating Chronic 60 EvaMist TM 60 toenail onychomycosis 60 Oxcarbazepine 60 Arzerra TM 60 Ridaforolimus 60 Study Showed 60 submitted Marketing Authorization 60 therefore therapeutically equivalent 60 Confirms Filing 60 Somatuline R Autogel R 60 Terbinafine 60 Hepatitis B Vaccine 60 Initiates Voluntary 60 GTC NASDAQ GTCB 60 refractory chronic lymphocytic 60 Taglich Brothers Initiates Coverage 60 HCl Tablets 60 investigational antiplatelet agent 60 TOPAMAX R 60 IONSYS TM 60 Momenta Pharmaceuticals MNTA 60 HCV Protease Inhibitor 60 Shown Effective 60 FDA Clearance 60 Entereg TM 60 Pharmaceuticals Initiates 60 Anemia Drug 60 memantine HCl 60 Nasdaq NBIX 60 Inhalation Aerosol 60 Obtains Approval 60 PDE# inhibitors 60 Nanoemulsion 60 CIP Fenofibrate 60 Successfully Treated 60 Glatiramer acetate 60 NGSX 60 beta 1a 60 Mg Usa 60 serotonin norepinephrine reuptake inhibitor 60 targeted radiotherapeutic 60 Cellegesic 60 Fungal Infections 60 miconazole Lauriad ® 60 Receives Confirmation 60 Nasdaq IPXL 60 Premarket Approval 60 Collegium Pharmaceutical Inc. 60 Generic Protonix 60 OTCBB DORB 60 Receptor Agonist 60 Emtriva Viread 60 NASDAQ ENMD 60 INSPIRE Trial Phase III 60 Aloprim TM allopurinol sodium 60 FDA Orphan Drug 60 Doripenem 60 ILUVIEN ® 60 Increlex TM 60 Rhucin ® recombinant 60 Troxatyl TM 60 STERIS Corporation Announces 60 BIOTECHNOLOGY SOURCE 60 TSX CTI 60 Corp EPCT 60 GW# [003] 60 norepinephrine reuptake inhibitor 60 zolpidem tartrate sublingual tablet 60 Bioral Amphotericin B 60 Ciclesonide 60 Receives Approvals 60 Wins Approval 60 euro adhoc Intercell AG 60 virus HCV protease inhibitor 60 II Clinical Trial 60 ALN PCS 60 Act PDUFA date 60 Gendux AB 60 Reduces Risk 60 MEMY 60 JZP 60 ® bortezomib 60 Anidulafungin 60 Q4 Loss Widens 60 R Saizen R 60 Data Suggest 60 website http:/www.celsion.com 60 novel oral anticoagulant 60 submit Biologics License 60 Selective Electrochemical Tumor Ablation 60 MEK Inhibitor 60 Q2 Loss Narrows 60 Antiarrhythmic 60 Slow Progression 60 Solorel ® 60 Neulasta R 60 R sorafenib tablets 60 TRANSDUR Bupivacaine 60 LGND 60 Board Authorizes 60 BAYRY 60 Expands Scientific Advisory 60 Completes Patient Enrolment 60 delivery polymer matrix 60 Announces Successful Completion 60 Transdermal Delivery 60 Zenpep 60 Nasdaq XTLB 60 Introduces Novel 60 REMOXY NDA 60 BioDelivery 60 Proquin 60 HEPLISAV ™ 60 Extina 60 Daclizumab 60 IgG1 monoclonal antibody 60 CHMP Opinion 60 Neutrolin 60 Inc NGSX 60 Confirms Receipt 60 Sunesis Pharma 60 fluvoxamine maleate 60 Alnylam Nasdaq ALNY 60 CancerVax Corporation 60 Receives Stockholder Approval 60 Therapeutic Competitors 60 LAF# 60 Improves Survival 60 Heartburn Drugs 60 Fondaparinux 60 novel synthetic peptide 60 NEXM 60 testosterone gel LibiGel 60 Phase 2a Study 60 cytomegalovirus immune globulin 60 Amex NVD 60 TransVax tm 60 ACUROX 60 Diabetic Nephropathy 60 Files Shelf Registration 60 myelodysplastic myeloproliferative diseases 60 Inc. Nasdaq IMGN 60 Aganocide ® 60 Complicated Skin 60 Announces Filing 60 NASDAQ POZN 60 Gets Approval 60 Receives Clearance From 60 sapropterin dihydrochloride 60 Inhaled Nitric Oxide 60 Alpha interferons including 60 Announces Shareholder Approval 60 XIAFLEX ® 60 Announces Termination 60 NASDAQ SHPGY 60 Oxaliplatin Injection 60 Nasdaq PHRM 60 Inc. www.micromet inc.com 60 R bendamustine hydrochloride 60 OTCBB PYTO 60 Roche Boniva 60 Study Demonstrates 60 ALVESCO ® 60 Announce Early Termination 60 Initiates Voluntary Recall 60 XIAFLEX ™ 60 Soriatane 60 Announces License Agreement 60 NASDAQ AVNR 60 treat opioid induced 60 TKPHF 60 proprietary Capillary Aerosolization Technology 60 Drug Maker 60 Durezol TM 60 Hepatic Encephalopathy 60 Fast Tracked 60 BLA filing 60 Begins Shipment 60 product platforms AZX# 60 Announces Effective Date 60 PANVAC VF 60 brivanib 60 Ista Pharmaceuticals Inc 60 DRRX 60 Nasdaq LGND 60 NerPharMa 60 Enters Into Collaboration 60 SIX RO ROG 60 ELADUR ™ 60 Commercialize Novel 59 Emezine 59 Anticancer Agent 59 Announces Issuance 59 Cutanea Life Sciences 59 GRAS Status 59 Diabetic Foot Ulcer 59 Iluvien TM 59 Investigational Device Exemption 59 OTC ZEGERID 59 Hydrochloride Tablets 59 OTCBB AMAR 59 k Premarket Notification 59 nasal decolonization 59 Approvable letter 59 Synvisc ONE 59 Ixabepilone 59 Corp. PHRM 59 Review Strategic Alternatives 59 Metastatic Melanoma 59 s Zyflo 59 Dexilant 59 Positive Opinion 59 Bertek Pharmaceuticals 59 Q2 Loss Widens 59 ONGLYZA ™ 59 highly selective inhibitor 59 duloxetine hydrochloride 59 Extends Collaboration 59 rhLF 59 Application BLA 59 Synthetic Peptide 59 XL# XL# 59 Lanthanum Carbonate 59 intravenous acetaminophen 59 targeted antifolate 59 Aztreonam 59 Liposomal 59 Inc. Nasdaq VVUS 59 OTCBB TDLP 59 Extend Collaboration 59 Anti Nausea 59 PHX# 59 Demonstrates Ability 59 severe hypercholesterolemia 59 antibiotic candidate Ramoplanin 59 lexidronam injection 59 Sodium Injection 59 Keppra ® XR 59 authority Gurian Sherman 59 NASDAQ DSCO 59 NM# [001] 59 Tumor Targeting 59 IIa Clinical Trial 59 Vidaza azacitidine 59 Circ Pharma 59 Bradmer Pharmaceuticals 59 BiDil XR 59 Fast Track designations 59 CRMD# 59 oxybutynin ATD TM 59 Phase lll 59 Cinacalcet HCl 59 BPAX 59 Product Monograph 59 topically applied SEPA 59 EcoNail TM 59 MAA submission 59 DIFICID ™ 59 ZEVALIN ® 59 Atypical Antipsychotic 59 Ambrisentan 59 rxRNA 59 Dose Escalation 59 Esbriet pirfenidone 59 WeissComm Partners +#-#-#-# 59 exclusive sublicense 59 Rylomine 59 C1 Inhibitor 59 autologous cellular immunotherapy 59 Liver Toxicity 59 Aztreonam lysine 59 Cefprozil tablets 59 Announces Consummation 59 Recurrent Glioblastoma 59 Zorbtive TM 59 STEDESA 59 Irinotecan Hydrochloride Injection 59 Indacaterol 59 Aldara ® 59 DURIN TM 59 Pimavanserin 59 RPTP 59 Receives CE 59 See CLINICAL PHARMACOLOGY 59 Anti Infective